{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:49:33Z","timestamp":1793170173649,"version":"4.5.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_raon-2020-0048_s_005_w2aab3b7c11b1b6b1aab1c16b1Aa\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic has disrupted the provision and use of healthcare services throughout the world. In Slovenia, an epidemic was officially declared between mid-March and mid-May 2020. Although all non-essential health care services were put on hold by government decree, oncological services were listed as an exception. Nevertheless, as cancer control depends also on other health services and additionally major changes in people\u2019s behaviour likely occurred, we aimed to analyse whether cancer diagnosis and management were affected during the COVID-19 epidemic in Slovenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2020-0048_s_006_w2aab3b7c11b1b6b1aab1c16b2Aa\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed routine data for the period November 2019 through May 2020 from three sources: (1) from the Slovenian Cancer Registry we analysed data on pathohistological and clinical practice cancer notifications from two major cancer centres in Ljubljana and Maribor; (2) from the e-referral system we analysed data on all referrals in Slovenia issued for oncological services, stratified by type of referral; and (3) from the administrative data of the Institute of Oncology Ljubljana we analysed data on outpatient visits by type as well as on diagnostic imaging performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2020-0048_s_007_w2aab3b7c11b1b6b1aab1c16b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to the November 2019 \u2013 February 2020 average, the decrease in April 2020 was about 43% and 29% for pathohistological and clinical cancer notifications; 33%, 46% and 85% for first, control and genetic counselling referrals; 19% (53%), 43% (72%) and 20% (21%) for first (and control) outpatient visits at the radiotherapy, surgery and medical oncology sectors at the Institute of Oncology Ljubljana, and 48%, 76%, and 42% for X-rays, mammograms and ultrasounds performed at the Institute, respectively. The number of CT and MRI scans performed was not affected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2020-0048_s_008_w2aab3b7c11b1b6b1aab1c16b4Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant drops in first referrals for oncological services, first visits and imaging studies performed at the Institute, as well as cancer notifications in April 2020 point to a possibility of a delayed cancer diagnosis for some patients during the first surge of SARS-CoV-2 cases in Slovenia. The reasons for the delay cannot be ascertained with certainty and could be linked to health-seeking behaviour of the patients, the beliefs and practices of doctors and\/ or the health system management during the epidemic. Drops in control referrals and control visits were expected and are most likely due to the Institute of Oncology Ljubljana postponing non-essential follow-ups through May 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/raon-2020-0048","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T09:42:21Z","timestamp":1596015741000},"page":"329-334","source":"Crossref","is-referenced-by-count":60,"title":["Impact of COVID-19 on cancer diagnosis and management in Slovenia \u2013 preliminary results"],"prefix":"10.2478","volume":"54","author":[{"given":"Vesna","family":"Zadnik","sequence":"first","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mihor","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Tomsic","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Zagar","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Bric","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Lokar","sequence":"additional","affiliation":[{"name":"Epidemiology and Cancer Registry, Institute of Oncology Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Oblak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute of Oncology Ljubljana , Ljubljana , Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2026071212043966171_j_raon-2020-0048_ref_001_w2aab3b7c11b1b6b1ab2ab1Aa","doi-asserted-by":"crossref","unstructured":"Amit M, Tam S, Bader T, Sorkin A, Benov A. Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2 pandemic: should we revisit the recommendations? Eur J Cancer 2020; 134: 86-9. doi: 10.1016\/j.ejca.2020.04.016","DOI":"10.1016\/j.ejca.2020.04.016"},{"key":"2026071212043966171_j_raon-2020-0048_ref_002_w2aab3b7c11b1b6b1ab2ab2Aa","doi-asserted-by":"crossref","unstructured":"Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo OC. Breast cancer diagnosis in coronavirus-era: alert from italy. Frontiers Oncol 2020; 10: 938. doi: 10.3389\/fonc.2020.00938","DOI":"10.3389\/fonc.2020.00938"},{"key":"2026071212043966171_j_raon-2020-0048_ref_003_w2aab3b7c11b1b6b1ab2ab3Aa","doi-asserted-by":"crossref","unstructured":"Vrdoljak E, Sullivan R, Lawler M. Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? Eur J Cancer 2020; 132: 98-9. doi: 10.1016\/j.ejca.2020.04.001","DOI":"10.1016\/j.ejca.2020.04.001"},{"key":"2026071212043966171_j_raon-2020-0048_ref_004_w2aab3b7c11b1b6b1ab2ab4Aa","unstructured":"Ordinance on interim measures in the field of health activities to contain and control the COVID-19 epidemic.[Slovenian]. Uradni list Republike Slovenije 32\/20; Ljubljana; 2020. [cited 2020 Jun 30]. Available at https:\/\/www.uradni-list.si\/glasilo-uradni-list-rs\/vsebina\/2020-01-0645\/odlok-ozacasnih-ukrepih-na-podrocju-zdravstvene-dejavnosti-zaradi-zajezitve-inobvladovanja-epidemije-covid-19"},{"key":"2026071212043966171_j_raon-2020-0048_ref_005_w2aab3b7c11b1b6b1ab2ab5Aa","doi-asserted-by":"crossref","unstructured":"Del Vecchio Blanco G, Calabrese E, Biancone L, Monteleone G, Paoluzi OA. The impact of COVID-19 pandemic in the colorectal cancer prevention. Int J Colorectal Dis 2020; [Ahead of print] 4 Jun 2020. doi:10.1007\/s00384-020-03635-6","DOI":"10.1007\/s00384-020-03635-6"},{"key":"2026071212043966171_j_raon-2020-0048_ref_006_w2aab3b7c11b1b6b1ab2ab6Aa","unstructured":"World Health Organization. Rapid assessment of service delivery for NCDs during COVID-19 pandemic Geneva; 2020."},{"key":"2026071212043966171_j_raon-2020-0048_ref_007_w2aab3b7c11b1b6b1ab2ab7Aa","doi-asserted-by":"crossref","unstructured":"Fong D, Rauch S, Petter C, Haspinger E, Alber M, Mitterer M. Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy. ESMO Open 2020; 5: e000810. doi: 10.1136\/esmoopen-2020-000810","DOI":"10.1136\/esmoopen-2020-000810"},{"key":"2026071212043966171_j_raon-2020-0048_ref_008_w2aab3b7c11b1b6b1ab2ab8Aa","doi-asserted-by":"crossref","unstructured":"van de Haar J, Hoes LR, Coles CE, Seamon K, Fr\u00f6hling S, J\u00e4ger D, et al. Caring for patients with cancer in the COVID-19 era. Nat Med 2020; 26: 665-71. doi: 10.1038\/s41591-020-0874-8","DOI":"10.1038\/s41591-020-0874-8"},{"key":"2026071212043966171_j_raon-2020-0048_ref_009_w2aab3b7c11b1b6b1ab2ab9Aa","doi-asserted-by":"crossref","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-7. doi: 10.1016\/S1470-2045(20)30096-6","DOI":"10.1016\/S1470-2045(20)30096-6"},{"key":"2026071212043966171_j_raon-2020-0048_ref_010_w2aab3b7c11b1b6b1ab2ac10Aa","doi-asserted-by":"crossref","unstructured":"Restivo A, De Luca R, Spolverato G, Delrio P, Lorenzon L, D\u2019Ugo D, et al. The need of COVID19 free hospitals to maintain cancer care. Eur J Surg Oncol 2020; 46: 1186-7. doi: 10.1016\/j.ejso.2020.04.003","DOI":"10.1016\/j.ejso.2020.04.003"},{"key":"2026071212043966171_j_raon-2020-0048_ref_011_w2aab3b7c11b1b6b1ab2ac11Aa","doi-asserted-by":"crossref","unstructured":"Mahase E. Covid-19: cancer research urges mass testing to enable care to continue during pandemic. BMJ 2020; 369: m1561. doi: 10.1136\/bmj.m1561","DOI":"10.1136\/bmj.m1561"},{"key":"2026071212043966171_j_raon-2020-0048_ref_012_w2aab3b7c11b1b6b1ab2ac12Aa","doi-asserted-by":"crossref","unstructured":"Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB. Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic. Br J Dermatol 2020; [Ahead of print] 4 Jun 2020. doi:10.1111\/bjd.19267","DOI":"10.1111\/bjd.19267"},{"key":"2026071212043966171_j_raon-2020-0048_ref_013_w2aab3b7c11b1b6b1ab2ac13Aa","doi-asserted-by":"crossref","unstructured":"Mahase E. Covid-19: Urgent cancer referrals fall by 60%, showing \u201cbrutal\u201d impact of pandemic. BMJ 2020; 369: m2386. doi: 10.1136\/bmj.m2386","DOI":"10.1136\/bmj.m2386"},{"key":"2026071212043966171_j_raon-2020-0048_ref_014_w2aab3b7c11b1b6b1ab2ac14Aa","doi-asserted-by":"crossref","unstructured":"Minucci A, Scambia G, Santonocito C, Concolino P, Urbani A. BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic. Mol Biol Rep 2020; 47: 4857-60. doi: 10.1007\/s11033-020-05479-3","DOI":"10.1007\/s11033-020-05479-3"},{"key":"2026071212043966171_j_raon-2020-0048_ref_015_w2aab3b7c11b1b6b1ab2ac15Aa","doi-asserted-by":"crossref","unstructured":"Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 2020; 21: 750-1. doi: 10.1016\/S1470-2045(20)30265-5","DOI":"10.1016\/S1470-2045(20)30265-5"},{"key":"#cr-split#-2026071212043966171_j_raon-2020-0048_ref_016_w2aab3b7c11b1b6b1ab2ac16Aa.1","doi-asserted-by":"crossref","unstructured":"De Vincentiis L, Carr RA, Mariani MP, Ferrara G. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology. J Clin Pathol 2020","DOI":"10.1136\/jclinpath-2020-206833"},{"key":"#cr-split#-2026071212043966171_j_raon-2020-0048_ref_016_w2aab3b7c11b1b6b1ab2ac16Aa.2","doi-asserted-by":"crossref","unstructured":"[Ahead of print] 19 June 2020. doi: 10.1136\/jclinpath-2020-206833","DOI":"10.1136\/jclinpath-2020-206833"},{"key":"2026071212043966171_j_raon-2020-0048_ref_017_w2aab3b7c11b1b6b1ab2ac17Aa","unstructured":"Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D. The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges. To the Point (blog), Commonwealth Fund 2020; Published Online First: 19 May 2020. [cited 2020 Jun 30]. Available at: https:\/\/www.commonwealthfund.org\/publications\/2020\/apr\/impact-covid-19-outpatient-visits doi: https:\/\/doi.org\/10.26099\/ds9e-jm36"},{"key":"2026071212043966171_j_raon-2020-0048_ref_018_w2aab3b7c11b1b6b1ab2ac18Aa","doi-asserted-by":"crossref","unstructured":"Sharpless NE. COVID-19 and cancer. Science 2020; 368: 1290. doi: 10.1126\/science.abd3377","DOI":"10.1126\/science.abd3377"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/raon\/54\/3\/article-p329.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2020-0048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:49:22Z","timestamp":1783900162000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2020-0048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2020,7,29]]}},"alternative-id":["10.2478\/raon-2020-0048"],"URL":"https:\/\/doi.org\/10.2478\/raon-2020-0048","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]}}}